CAMBRIDGE, Mass.–(BUSINESS WIRE)–METiS today announced officially joining the Roche Accelerator with the goal to tap into Roche’s global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai. “We are excited to become a member of the Roche Accelerator and to establish a closer connection with a … [Read more…]
Brandywine’s premier properties have implemented WellAir’s portfolio of IAQ solutions in elevators and select conference rooms to help improve and protect their indoor environments. STAMFORD, Conn.–(BUSINESS WIRE)–WellAir, a leading provider of indoor air disinfection and purification solutions, today announced the implementation of its solutions in the elevator cabs throughout Brandywine’s entire Trophy Class of buildings … [Read more…]
Pregistry’s Latest Recruitment Brings Senior Executive Talent to the Team LOS ANGELES–(BUSINESS WIRE)–#CMO—Pregistry, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company’s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing … [Read more…]
– Data from the Phase 1 dose-escalation portion of the Phase 1/2 EXACT study demonstrate XC001 was well-tolerated at all dose levels tested; highest dose level evaluated selected for ongoing Phase 2 portion of the study – Preliminary efficacy data highlight XC001 potential for patients with refractory angina with no other treatment options – Treatment … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Today Viseon Inc. announced that it recently achieved over 1,000 U.S. Minimally Invasive Spine Surgery cases utilizing the Viseon MaxView Imaging Platform. MaxView is a state-of-the-art intraoperative imaging technology that enables a highly magnified unobstructed view of the surgical corridor and critical anatomy projected in real time onto operating room flat panel displays … [Read more…]
New funding will support ongoing clinical development of lead candidate, SBT101 for adrenomyeloneuropathy (AMN) Phase 1/2 study initiation of SBT101 expected in the second half of 2022 Pipeline development to continue, focused on spinal cord-related disorders PHILADELPHIA–(BUSINESS WIRE)–SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological … [Read more…]
SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, May 25, 2022, at 9:15 am ET. … [Read more…]
Nine Seasoned Banking Professionals Comprise New Private Client Banking Team to Serve Healthcare Industry NEW YORK–(BUSINESS WIRE)–Signature Bank (Nasdaq: SBNY), a New York-based, full-service commercial bank, announced today the launch of a new business line with the appointment of a nine-person Healthcare Banking and Finance (HBF) team. The new private client banking team will provide … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The global senolytic drugs market is expected to grow at a significant rate during … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets 2022 to 2026: Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. “ report has been added to ResearchAndMarkets.com’s offering. Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is … [Read more…]
